I. Project Name: Minhai Biotechnology New‑Type Vaccine International Industrial Base Construction Project II. Project Overview: The Minhai Biotechnology New‑Type Vaccine International Industrial Base Construction Project, invested and developed by Beijing Minhai Biotechnology Co., Ltd., is located on parcels 0503‑039, 040, 043, and 044 within the Daxing Biomedical Industry Base. The project’s boundaries are as follows: north to Simiao Road; south to the planned land boundary (municipal green space); west to Xiangrui Avenue; and east to Tianfu Avenue. This project is primarily intended for the research, development, and production of human vaccines. Construction Scale: The total land area is 90,013.218 m², with a total floor area of 187,684.83 m² (including 130,410.84 m² above ground and 57,273.99 m² underground). Building heights range from 33.3 meters, with one basement level and seven above‑ground floors. Basement floor-to-floor heights are 6 meters, while above‑ground heights vary between 3.8 and 7.9 meters. The green space ratio is 15%, the floor area ratio is 1.5, and the building density is 40%. Design Period: October 2020 – October 2021. III. Scope of Tender: 1. Scope of Tender: This tender covers interior fit‑out design and exterior curtain wall design for the Minhai Biotechnology New‑Type Vaccine International Industrial Base Construction Project. a) Interior Fit‑Out Design: Key tasks include: - Conceptual design (including animation walkthroughs, renderings, and preparation of design documentation); - Schematic design (including animation walkthroughs, renderings, and preparation of design documentation); - Construction drawing design; - General contracting for interior fit‑out works (coordinating with laboratory and cleanroom engineering specialists). b) Exterior Curtain Wall Design: Key tasks include: - Detailed schematic design (including animation walkthroughs, renderings, and preparation of design documentation); - Construction drawing design. 2. Design Scope (specific floor areas are listed in the table below): - Interior fit‑out design for public areas in Buildings No. 1, 8, 9, and 10; - Interior fit‑out design for Buildings No. 2, 3, 13, 14, and 15; - Interior fit‑out design for the civil‑use portion of Building No. 12; - Exterior curtain wall design for Buildings No. 1 through 15. 3. Floor Areas: | No. | Project Type | Total Floor Area (m²) | Above‑Ground Floor Area (m²) | Below‑Ground Floor Area (m²) | Number of Floors | Height (m) | |-----|--------------|-----------------------|-------------------------------|-------------------------------|-----------------|------------| | 1 | R&D Pilot Plant | 41,596.95 | 41,596.95 | — | 6 | 13.18–6.0 | | 2 | R&D Technical Workshop | 14,852.14 | 14,852.14 | — | 7 | 13.16–6.0 | | 3 | Comprehensive Service Building | 14,040.32 | 14,040.32 | — | 6 | 12.45–6.0 | | 8 | Vaccine Production Building | 16,771.16 | 16,771.16 | — | 4 | 13.3–6.0 | | 9 | Packaging and Warehousing Building | 15,765.58 | 15,765.58 | — | 4 | 13.3–6.0 | | 10 | Bacterial Vaccine Production Building | 19,807.00 | 19,807.00 | — | 4 | 13.3–6.0 | | 11 | Basement Level 12 | 55,933.02 | 55,933.02 | 55,933.94 | 13.9–6.0 | | 12 | Gatehouse and Carport Level 13 | 370.80 | 370.80 | — | 13.9–6.0 | | 13 | Gatehouse Level 14 | 29.83 | 29.83 | — | 13.9–6.0 | | 14 | Gatehouse Level 15 | 59.66 | 59.66 | — | 13.9–6.0 | IV. Registration Instructions: 1. Participating entities must submit the following documents: business license, qualification certificates, legal representative certificate or power of attorney, and a copy of the legal representative’s ID card (copies must bear the official seal of the company), along with details of the company’s registered capital. 2. Bidders must possess qualifications in both interior fit‑out design and exterior curtain wall design. Additionally, the applying organization and its lead design team must have demonstrated experience in the following areas: - Interior fit‑out projects for national or provincial public venues, such as expo centers, convention centers, art centers, and cultural halls; - Interior fit‑out projects for office spaces of national, provincial, or Fortune Global 500 companies, including headquarters, office buildings, and conference centers; - Interior fit‑out projects for residential, hotel, and apartment developments among China’s top ten real estate developers; - Exterior curtain wall projects for national or provincial public venues, office spaces, or pharmaceutical industrial parks. 3. Registrants must provide contact information for a designated representative, who should be the project manager or an appointed liaison, along with proof of social insurance coverage for the past 12 months. 4. The tenderer will review all submitted qualification documents, giving priority to applicants with relevant project experience, and will conduct further discussions and site visits with shortlisted candidates. 5. Beijing Minhai Biotechnology Co., Ltd. was established in 2004 and is a wholly owned subsidiary of Shenzhen Kangtai Biological Products Co., Ltd. (a publicly listed company). For more information, please visit the company’s website. V. Registration Details: 1. After registering by phone, bidders should send their qualification documents to the designated registration email address. 2. Contact Information: Beijing Minhai Biotechnology Co., Ltd., No. 35 Simiao Road, Daxing District, Beijing. Contact persons: Mr. Hao, Ms. Fang, and Mr. Wu from the New Project Department; telephone numbers: 010‑57864910 and 010‑57864916. Registration email: mhzb@biominhai.com. VI. Registration Deadline: 5:30 p.m., October 16, 2020. Hereby announced! Beijing Minhai Biotechnology Co., Ltd. October 9, 2020